Using multiple breast cancer cell line models (MDA-MB-468, BT-549, HCC-1954), we identified STAT-3 signaling to be a cell line-dependent factor determining cancer cell survival following LDHC silencing. This evidence concerns the gene STAT3 and hepatocellular carcinoma.